Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies.
Koeppel F, Muller E, Harlé A, Guien C, Sujobert P, Trabelsi Grati O, Kosmider O, Miguet L, Mauvieux L, Cayre A, Salgado D, Preudhomme C, Karayan-Tapon L, Tachon G, Coulet F, Lespagnol A, Beroud C, Leroy K, Rouleau E, Soubeyran I. Koeppel F, et al. Among authors: preudhomme c. Eur J Cancer. 2021 Dec;159:1-15. doi: 10.1016/j.ejca.2021.08.047. Epub 2021 Oct 23. Eur J Cancer. 2021. PMID: 34700215
Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
Pérez B, Kosmider O, Cassinat B, Renneville A, Lachenaud J, Kaltenbach S, Bertrand Y, Baruchel A, Chomienne C, Fontenay M, Preudhomme C, Cavé H. Pérez B, et al. Among authors: preudhomme c. Br J Haematol. 2010 Dec;151(5):460-8. doi: 10.1111/j.1365-2141.2010.08393.x. Epub 2010 Oct 19. Br J Haematol. 2010. PMID: 20955399 Free article.
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion.
Chesnais V, Renneville A, Toma A, Lambert J, Passet M, Dumont F, Chevret S, Lejeune J, Raimbault A, Stamatoullas A, Rose C, Beyne-Rauzy O, Delaunay J, Solary E, Fenaux P, Dreyfus F, Preudhomme C, Kosmider O, Fontenay M; Groupe Francophone des Myélodysplasies. Chesnais V, et al. Among authors: preudhomme c. Blood. 2016 Feb 11;127(6):749-60. doi: 10.1182/blood-2015-04-640128. Epub 2015 Dec 1. Blood. 2016. PMID: 26626993 Free PMC article. Clinical Trial.
Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study.
Marino P, Touzani R, Perrier L, Rouleau E, Kossi DS, Zhaomin Z, Charrier N, Goardon N, Preudhomme C, Durand-Zaleski I, Borget I, Baffert S; NGSEco Group:. Marino P, et al. Among authors: preudhomme c. Eur J Hum Genet. 2018 Mar;26(3):314-323. doi: 10.1038/s41431-017-0081-3. Epub 2018 Jan 24. Eur J Hum Genet. 2018. PMID: 29367707 Free PMC article.
Correction: Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study.
Marino P, Touzani R, Perrier L, Rouleau E, Kossi DS, Zhaomin Z, Charrier N, Goardon N, Preudhomme C, Durand-Zaleski I, Borget I, Baffert S; NGSEco Group:. Marino P, et al. Among authors: preudhomme c. Eur J Hum Genet. 2018 Sep;26(9):1396-1397. doi: 10.1038/s41431-018-0194-3. Eur J Hum Genet. 2018. PMID: 29907756 Free PMC article.
The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies.
Sujobert P, Le Bris Y, de Leval L, Gros A, Merlio JP, Pastoret C, Huet S, Sarkozy C, Davi F, Callanan M, Thieblemont C, Sibon D, Asnafi V, Preudhomme C, Gaulard P, Jardin F, Salles G, Macintyre E. Sujobert P, et al. Among authors: preudhomme c. Hemasphere. 2018 Dec 27;3(1):e169. doi: 10.1097/HS9.0000000000000169. eCollection 2019 Feb. Hemasphere. 2018. PMID: 31723808 Free PMC article.
Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience.
Diarra A, Duployez N, Fournier E, Preudhomme C, Coiteux V, Magro L, Quesnel B, Heiblig M, Sujobert P, Barraco F, Balsat M, Scanvion Q, Hachulla E, Launay D, Yakoub-Agha I, Terriou L. Diarra A, et al. Among authors: preudhomme c. Blood Adv. 2022 Feb 8;6(3):998-1003. doi: 10.1182/bloodadvances.2021004749. Blood Adv. 2022. PMID: 34714914 Free PMC article.
Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience.
Alary AS, Maute C, Kosmider O, Sujobert P, Gauthier A, Macintyre E, Preudhomme C, Hayette S, Luque-Paz D, Baran-Marszak F, Davi F, Lippert E, Cornillet-Lefebvre P, Delfau-Larue MH, Cassinat B, Cayuela JM, Flandrin-Gresta P. Alary AS, et al. Among authors: preudhomme c. Hemasphere. 2021 Nov 17;5(12):e658. doi: 10.1097/HS9.0000000000000658. eCollection 2021 Dec. Hemasphere. 2021. PMID: 34805765 Free PMC article.
Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group.
Fournier E, Heiblig M, Lespinasse C, Flandrin-Gresta P, Geay A, Miguet L, Fenwarth L, Vallat L, Soubeyrand B, Marceau-Renaut A, Plesa A, Preudhomme C, Sujobert P, Hayette S, Duployez N, Huet S. Fournier E, et al. Among authors: preudhomme c. Leukemia. 2022 May;36(5):1390-1400. doi: 10.1038/s41375-022-01534-z. Epub 2022 Mar 7. Leukemia. 2022. PMID: 35256762 No abstract available.
MDM2 gene amplification in human breast cancer.
Quesnel B, Preudhomme C, Fournier J, Fenaux P, Peyrat JP. Quesnel B, et al. Among authors: preudhomme c. Eur J Cancer. 1994;30A(7):982-4. doi: 10.1016/0959-8049(94)90128-7. Eur J Cancer. 1994. PMID: 7946596
395 results